Mason EF, Kuo FC, Hasserjian RP, Seegmiller AC, Pozdnyakova O. A distinct immunophenotype identifies a subset of NPM1‐mutated AML with TET2 or IDH1/2 mutations and improved outcome. American J Hematol. 2018 Jan 25;93(4):504–10. doi: 10.1002/ajh.25018.